GSA Capital Partners’s Entrada Therapeutics TRDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-36,577	Closed	-$585K	–	2036
2024 Q3	$585K	Buy	36,577 +15,284	+72%	+$244K	0.04%	818
2024 Q2	$303K	Buy	+21,293	New	+$303K	0.02%	1278